French drug maker Sanofi will announce the price of the potential COVID19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.
PARIS: French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain’s GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.
The company is expected to release the results from the Phase I/II clinical trials this month.
It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor
Read all the Latest News, Breaking News and Coronavirus News here
Comments
0 comment